Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Naike Casagrande"'
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 172, Iss , Pp 116296- (2024)
Ovarian cancer (OC) is the fifth most frequent cause of cancer-related death in women. Chemotherapy agent trabectedin, affecting cancer cells and tumor microenvironment, has been approved for the treatment of relapsed platinum-sensitive OC patients.
Externí odkaz:
https://doaj.org/article/4443b403b3c04ebe805c284f263a4aa9
Publikováno v:
Cells, Vol 12, Iss 23, p 2732 (2023)
Classical Hodgkin lymphoma (cHL) is a highly curable disease (70–80%), even though long-term toxicities, drug resistance, and predicting clinical responses to therapy are major challenges in cHL treatment. To solve these problems, we characterized
Externí odkaz:
https://doaj.org/article/5567711cca3744e0a3ca1675732d40b1
Publikováno v:
Haematologica, Vol 107, Iss 1 (2021)
Externí odkaz:
https://doaj.org/article/e57f1925d84d41518dc688313caa2dd4
Autor:
Naike Casagrande, Cinzia Borghese, Lydia Visser, Maurizio Mongiat, Alfonso Colombatti, Donatella Aldinucci
Publikováno v:
Haematologica, Vol 104, Iss 3 (2019)
Classic Hodgkin lymphoma tumor cells express a functional CCR5 receptor, and tumor tissues express high CCL5 levels, suggesting that CCL5-CCR5 signaling is involved in tumor-microenvironment formation and tumor growth. Using the CCR5 antagonist, mara
Externí odkaz:
https://doaj.org/article/bb8deb98912f4559970233c898f842ee
Publikováno v:
Pharmaceutics, Vol 12, Iss 5, p 401 (2020)
Adipose-derived stem cells (ADSCs) primed with paclitaxel (PTX) are now hypothesized to represent a potential Trojan horse to vehicle and deliver PTX into tumors. We analyzed the anticancer activity of PTX released by ADSCs primed with PTX (PTX-ADSCs
Externí odkaz:
https://doaj.org/article/70442d0ba6a04056a7ab5da622b3cade
Autor:
Adam A. A. Sulaiman, Naike Casagrande, Cinzia Borghese, Giuseppe Corona, Anvarhusein A. Isab, Saeed Ahmad, Donatella Aldinucci, Muhammad Altaf
Publikováno v:
Journal of Medicinal Chemistry. 65:14424-14440
A new series of seven gold(I) complexes (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::350e897a4667e7c4f47385d666a5d8e9
https://doi.org/10.1021/acs.jmedchem.2c00737
https://doi.org/10.1021/acs.jmedchem.2c00737
Autor:
Donatella Aldinucci, Alfonso Colombatti, Maurizio Mongiat, Cinzia Borghese, Marta Celegato, Naike Casagrande
Table S2. Combination index (CI) values for OVCAR5 and SKOV3 cell lines treated with Carboplatin and Doxorubicin, Abraxane, Docetaxel or Paclitaxel.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::002a3764dee555db320ef3ee6bacfbd3
https://doi.org/10.1158/1078-0432.22461486
https://doi.org/10.1158/1078-0432.22461486
Autor:
Donatella Aldinucci, Alfonso Colombatti, Maurizio Mongiat, Cinzia Borghese, Marta Celegato, Naike Casagrande
Purpose: Cisplatin and its platinum derivatives are first-line chemotherapeutic agents in the treatment of ovarian cancer; however, treatment is associated with tumor resistance and significant toxicity. Here we investigated the antitumoral activity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37eb63e705e1b069fb87520f49e207cf
https://doi.org/10.1158/1078-0432.c.6524796.v1
https://doi.org/10.1158/1078-0432.c.6524796.v1
Autor:
Donatella Aldinucci, Alfonso Colombatti, Maurizio Mongiat, Cinzia Borghese, Marta Celegato, Naike Casagrande
Figure S3. Cisplatin activity in SKOV3 spheroids and OVCAR5 tumor xenograft
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89c721b6c778f479f3f9d6691a12166c
https://doi.org/10.1158/1078-0432.22461495.v1
https://doi.org/10.1158/1078-0432.22461495.v1
Autor:
Donatella Aldinucci, Alfonso Colombatti, Maurizio Mongiat, Cinzia Borghese, Marta Celegato, Naike Casagrande
Conflict of Interest Form
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09afe47a6a7081aa71b87750ba58a3c8
https://doi.org/10.1158/1078-0432.22461504.v1
https://doi.org/10.1158/1078-0432.22461504.v1